Findings

What do systematic reviews say?

3 questions · 3 findings · 1 reviews · Gynaecology and Fertility

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 33.3%Low 1 · 33.3%Moderate 1 · 33.3%High 0 · 0%

Closest answers

The findings closest to your search, judged one by one by TypeSafe's Jev model.

Related · question page
- Human menopausal gonadotrophin or highly purified human menopausal gonadotrophin vs urinary follicle stimulating hormone · Incidence of multiple pregnancy (per woman)
  Gonadotrophins for ovulation induction in women with polycystic ovary syndrome 2019 · Cochrane Headline outcomes only
  RR 2.13 [0.51, 8.91]
  4 studies · 161 participants
  Very low
Related · question page
- Recombinant follicle stimulating hormone vs urinary‐derived gonadotrophins · Incidence of multiple pregnancy (per woman)
  Gonadotrophins for ovulation induction in women with polycystic ovary syndrome 2019 · Cochrane Headline outcomes only
  RR 0.86 [0.46, 1.61]
  8 studies · 1368 participants
  Low
Related · question page
- Gonadotrophins vs continued clomiphene citrate · Incidence of multiple pregnancy per woman
  Gonadotrophins for ovulation induction in women with polycystic ovary syndrome 2019 · Cochrane Headline outcomes only
  RR 0.89 [0.33, 2.4]
  1 study · 661 participants
  Moderate

Gonadotrophins vs continued clomiphene citrate

Multiple pregnancy rate · anovulatory women with clomiphene citrate‐failure

Gonadotrophins showed no clear difference in incidence of multiple pregnancy per woman compared with continued clomiphene citrate (moderate certainty).

1 finding from 1 review

Gonadotrophins for ovulation induction in women with polycystic ovary syndrome 2019 · Cochrane Headline outcomes only
RR 0.89 [0.33, 2.4]
1 study · 661 participants
Moderate

Recombinant follicle stimulating hormone vs urinary‐derived gonadotrophins

Multiple pregnancy rate · ovulation induction in polycystic ovarian syndrome

Recombinant follicle stimulating hormone showed no clear difference in incidence of multiple pregnancy (per woman) compared with urinary‐derived gonadotrophins (low certainty).

1 finding from 1 review

Gonadotrophins for ovulation induction in women with polycystic ovary syndrome 2019 · Cochrane Headline outcomes only
RR 0.86 [0.46, 1.61]
8 studies · 1368 participants
Low

Human menopausal gonadotrophin or highly purified human menopausal gonadotrophin vs urinary follicle stimulating hormone

Multiple pregnancy rate · ovulation induction in polycystic ovarian syndrome

It is very uncertain whether human menopausal gonadotrophin or highly purified human menopausal… changes incidence of multiple pregnancy (per woman) compared with urinary follicle stimulating hormone (very low certainty).

1 finding from 1 review

Gonadotrophins for ovulation induction in women with polycystic ovary syndrome 2019 · Cochrane Headline outcomes only
RR 2.13 [0.51, 8.91]
4 studies · 161 participants
Very low